News | News By Subject | News by Disease News By Date | Search News

Leukemia News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Bernie Sanders Demands Info on Ariad (ARIA)'s Leukemia Drug     10/24/2016
FDA Berates Celator Pharma (CPXX) for Pushing Unapproved Leukemia Drug to Doctors     9/8/2016
KaloBios (KBIO) Fires Martin Shkreli, UC Davis Suspends Leukemia Trial Due to Shkreli     12/23/2015
Poland’s Selvita Stakes Out its Own Space in U.S. Pharma Hubs of Boston and San Francisco     9/18/2015
Amgen (AMGN) Deal Brings Xencor $45M Up Front, Setup for $1.7B in Milestones     9/16/2015
Step Aside Juno (JUNO): World's Richest Doctor Pulls Off Largest Biotech IPO Ever     8/4/2015
FDA OKs Juno (JUNO)'s IND for Lead Leukemia Candidate JCAR015     8/3/2015
Amgen (AMGN) Lauds Positive Phase II Data for Leukemia Drug Blincyto     7/17/2015
Baxter International (BAX) Puts Down $900 Million to Beef Up Cancer Products for Spinoff     5/13/2015
AbbVie (ABBV), Genentech (RHHBY) Leukemia Drug Wins Breakthrough Status Tag     5/11/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
AbbVie (ABBV) Overpaid in Pharmacyclics (PCYC) Deal, For Only 50% Rights to Imbruvica: Analyst     3/6/2015
EXCLUSIVE: Experimental Cancer Drug From Oncoceutics Could Be Fast-Tracked, Says Exec     3/6/2015
Eagle Pharmaceuticals (EGRX), Teva Pharmaceutical Industries (TEVA) Forge $120 Million Leukemia Drug Pact     2/18/2015
Amgen (AMGN)'s Blincyto To Carry A Hefty $178,000 Price Tag     12/19/2014

News from Around the Web
2 Babies With Leukemia Are In Remission More Than A Year After Getting Treated With Gene-Edited Cells     1/27/2017
A New Antibody For Treating Acute Lymphocytic Leukemia?     12/6/2016
Small-Molecule Tool Could Reduce Leukemia Cell Regeneration, University of California, San Diego (UCSD) Study     6/13/2016
Body's Own Gene Editing System Generates Leukemia Stem Cells, University of California San Diego School of Medicine Study Reveals     6/10/2016
Untested ‘Designer Cell’ Treatment Saved One Year Old From Leukemia, Great Ormond Street Hospital Reveals     4/11/2016
Main Ingredient Of Artificial Sweetener Splenda Linked To Leukemia, Study Published In International Journal Of Occupational And Environmental Health     3/14/2016
Umbilical Blood Cells Kill Cancer Quicker Than Adult Cells, Great Ormond Street Hospital For Children Study     2/8/2016
New Way For Early Detection Of Potentially Deadly Fungal Infection In Leukemia Patients Discovered, University of Texas Medical Branch at Galveston Researchers Reveal     12/15/2015
Designer Cells Cure One-Year Old Cancer Patient, Nature Reveals     11/6/2015
Avocados May Help Fight Blood Cancer, University Of Waterloo Study     6/17/2015
How Red Wine Prevents Cancer, University of Colorado Study     12/5/2014
New Drug May Be Effective Against Many Cancer Types, University College London Study     6/13/2014
Drugs To Watch: Potential Blockbusters Of 2014     4/17/2014
Mutations In Leukemia Gene Linked To New Childhood Growth Disorder, The Institute of Cancer Research Study     3/10/2014
Discovery of Novel Gene Mutations in Leukemia Patients Opens Up Personalized Therapy Options, Ludwig-Maximilians-University and Helmholtz Zentrum Munchen Study     8/5/2013

Press Releases
City of Hope Researchers Discover Sugar-Addiction Of Cancer Cells In Childhood Leukemia     2/14/2017
CRT Pioneer Fund And Cardiff University Announce The Initiation Of The Phase II MONOCLE Study Of Tefinostat For The Treatment Of Chronic Myelomonocytic Leukaemia With Funding To Progress Further Development     2/8/2017
AstraZeneca PLC (AZN) Release: Early Data Demonstrate Clinical Activity Of Acalabrutinib In Difficult-to-Treat Chronic Lymphocytic Leukemia     12/6/2016
Arvinas Collaborators Present Data On BET PROTAC Degraders At 2016 American Society of Hematology Annual Meeting     12/6/2016
AbbVie (ABBV) Release: IMBRUVICA (ibrutinib) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma 5-Year Analysis And Long-Term RESONATE-2 Follow-Up Data At American Society of Hematology 2016 Show Lasting Efficacy     12/5/2016
Children's Hospital of Philadelphia Release: In Clinical Trials, CAR T Cell Immunotherapy Continues To Yield Complete Responses In Children & Young Adults With Relapsed And Refractory Leukemia     12/5/2016
Synpromics Announces Collaboration With Sartorius Stedim Cellca To Develop Improved Biologicals Manufacturing Process Using Synthetic Promoters     12/5/2016
ERYtech Pharma Presents New Data On GRASPA’s Mechanism Of Action At American Society of Hematology Annual Meeting     12/1/2016
Teva (TEVA) Secures European Approval Of Trisenox For First Line Treatment Of Low To Intermediate Risk Acute Promyelocytic Leukemia (APL)     11/21/2016
Imago Biosciences Enrolls First Patient In Phase 1/2 Study Of IMG-7289 In Acute Myeloid Leukemia And Myelodysplastic Syndrome     11/9/2016
Salk Institute for Biological Studies Release: Heart Disease, Leukemia Linked To Dysfunction In Nucleus     11/4/2016
Nordic Nanovector And Heidelberg Pharma Enter Collaboration To Develop Novel Antibody-Drug Conjugates (ADCs) Targeting Leukaemias     10/26/2016
Cellerant Therapeutics, Inc. Presents Preclinical Data Showing Promise Of A Novel Differentiated Target On Leukemic Stem Cells     10/11/2016
Amgen (AMGN) Release: Study Results Published In Journal Of Clinical Oncology Show BLINCYTO (Blinatumomab) Induced Complete Remission In Heavily Pretreated Pediatric Patients With Philadelphia Chromosome-Negative Relapsed Or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia     10/4/2016
Eisai Company (ESALY.PK) Release: Anticancer Agent "Treakisym For Injection 100 Mg" Approved In Japan For Additional Indication Of Chronic Lymphocytic Leukemia     8/26/2016

//-->